Lexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Lexicon Pharmaceuticals (NASDAQ: LXRX) has scheduled its first quarter 2025 financial results announcement for Tuesday, May 13, 2025, after market close. The company will host a conference call and live webcast at 5:00 p.m. ET (4:00 p.m. CT) on the same day, where management will discuss the quarterly results and provide a business update. Interested participants can access the webcast through the Events page on Lexicon's investor website, while those wishing to ask questions during the call can register to receive dial-in information. An archived version of the webcast will be made available on the company's website for later viewing.

05/06/2025 - 08:00 AM

THE WOODLANDS, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its first quarter 2025 financial results on Tuesday, May 13, 2025, after the markets close. Management will conduct a conference call and live webcast at 5:00 p.m. ET (4:00 p.m. CT) that day to discuss the financial results and to provide a business update.

Participants can access the conference call live via webcast on the Events page of the Company’s website at https://investors.lexpharma.com/. Participants who wish to ask a question may register here to receive dial-in numbers and a unique pin to join the call. An archived version of the webcast will be available on the Lexicon website.

About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique genomics target discovery platform, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon has advanced multiple medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in heart failure, neuropathic pain, obesity, cardiology, diabetes and other indications. For additional information, please visit www.lexpharma.com.

For Investor and Media Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com

FAQ

When will Lexicon Pharmaceuticals (LXRX) report Q1 2025 earnings?

Lexicon Pharmaceuticals will report its Q1 2025 earnings on Tuesday, May 13, 2025, after the markets close.

What time is Lexicon Pharmaceuticals' Q1 2025 earnings call?

Lexicon's Q1 2025 earnings conference call is scheduled for 5:00 p.m. ET (4:00 p.m. CT) on May 13, 2025.

How can investors access Lexicon Pharmaceuticals' Q1 2025 earnings call?

Investors can access the live webcast through Lexicon's investor website at investors.lexpharma.com/events, or register to receive dial-in numbers for the conference call.